Schizophrenia Treatments: Medication & Therapy
Choosing Therapy strives to provide our readers with mental health content that is accurate and actionable. We have high standards for what can be cited within our articles. Acceptable sources include government agencies, universities and colleges, scholarly journals, industry and professional associations, and other high-integrity sources of mental health journalism. Learn more by reviewing our full editorial policy.
Howes, O. D., et. al. (2021). The clinical significance of duration of untreated psychosis: An umbrella review and random-effects meta-analysis. World Psychiatry, 20(1), 75–95. https://doi.org/10.1002/wps.20822
Keepers, G. A., et. al. (2020). The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia. American Journal of Psychiatry, 177(9), 868–872.
Review of Research Evidence Supporting Guideline Statements. (2020). In The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia. American Psychiatric Association Publishing.
Veselinović, T., et. al (2019). Disparate effects of first and second generation antipsychotics on cognition in schizophrenia – Findings from the randomized NeSSy trial. European Neuropsychopharmacology, 29(6), 720–739.
Solmi, M., et. al. (2017). Safety, tolerability, and risks associated with first- and second-generation antipsychotics: A state-of-the-art clinical review. Therapeutics and Clinical Risk Management, 13, 757–777.
McDonagh, M. S., et. al. (2022). Psychosocial Interventions for Adults With Schizophrenia: An Overview and Update of Systematic Reviews. Psychiatric Services, 73(3), 299–312.
Grover, S., Sahoo, S., Rabha, A., & Koirala, R. (2019). ECT in schizophrenia: A review of the evidence. Acta Neuropsychiatrica, 31(03), 115–127. https://doi.org/10.1017/neu.2018.32